Search IPOs
LAXMIDENTL · NSE,BSE · Medical Equipment & Supplies
Laxmi Dental IPO listed on 20 Jan 2025 on NSE,BSE at ₹542.00, a gain of 26.64% over the issue price of ₹428.00. The IPO was subscribed 114.42x overall.
Laxmi Dental IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 13 Jan 2025 |
| IPO Close Date | 15 Jan 2025 |
| Basis of Allotment | 16 Jan 2025 |
| Initiation of Refunds | 17 Jan 2025 |
| Credit of Shares to Demat | 17 Jan 2025 |
| Listing Date | 20 Jan 2025 |
Listing day gain
+26.64%
Listed at ₹542 (issue ₹428)
Issue
₹428
Listing
₹542
Current
₹550.55
+28.63% vs issue
Day range
₹525 – ₹584
Issue Size
16,309,766 shares
(aggregating up to ₹698.06 Cr)
Issue Price
₹407 – ₹428
Face Value
₹2/share
Market Lot
33 shares
Retail Min Investment
₹14,124
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
3,224,299 shares
(aggregating up to ₹138 Cr)
Offer for Sale
13,085,467 shares
(aggregating up to ₹560.06 Cr)
Issue Type
book building
Open Date
13 Jan
Close Date
15 Jan
Allotment
16 Jan
Listing
20 Jan
Last updated: 1 year ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 19 Jan 2025 Latest | ₹428 | ₹145 | ₹573 | ₹145 |
33.88%
|
12:00 AM |
| 18 Jan 2025 | ₹428 | ₹137 | ₹565 | ₹137 |
32.01%
|
12:00 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 15 Jan 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 110.38x |
| NII | 147.95x |
| bNII (bids above ₹10L) | 167.68x |
| sNII (bids below ₹10L) | 108.49x |
| Retail Investors | 76.23x |
| Total | 114.42x |
Showing the latest subscription snapshot.
View full subscription historyRajesh Vrajlal Khakhar, Sameer Kamlesh Merchant and Dharmesh Bhupendra Dattani n
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,124 |
| Retail (Max) | 14 | 462 | ₹197,736 |
| S-HNI (Min) | 15 | 495 | ₹211,860 |
| S-HNI (Max) | 70 | 2,310 | ₹988,680 |
| B-HNI (Min) | 71 | 2,343 | ₹1,002,804 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 12,232,326 (75.00%) |
|
•
Anchor Investor Shares Offered
|
7,339,395 (45.00%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
4,892,931 (30.00%) |
| NII (HNI) Shares Offered | 2,446,464 (15.00%) |
|
•
bNII > ₹10L
|
1,630,976 (10.00%) |
|
•
sNII < ₹10L
|
815,488 (5.00%) |
| Retail Shares Offered | 1,630,976 (10.00%) |
| Total Shares Offered | 16,309,766 (100.00%) |
Laxmi Dental Limited was incorporated in July 2004 and is headquartered in Andheri (West), Mumbai. It works in the dental products manufacturing sector.
The company operates as an end-to-end integrated dental products business, offering custom-made crowns and bridges, branded dental products such as clear aligners and thermoforming sheets, aligner-related products under the Taglus brand, biocompatible 3D printing resins, and pediatric dental products including the Bioflx dental crown. As of September 30, 2024, it operated six manufacturing facilities, three in Mira Road, Mumbai, two in Boisar, and one in Kochi, along with supporting facilities in Mumbai, Delhi, Bengaluru, and Ahmedabad. Exports, mainly to the US and UK, account for a significant share of revenue. The promoters are Rajesh Vrajlal Khakhar, Sameer Kamlesh Merchant, and Dharmesh Bhupendra Dattani.
On a restated basis, revenue from operations rose from Rs 136.84 crore in FY22 to Rs 161.63 crore in FY23 to Rs 193.55 crore in FY24, with the company moving from losses in FY22 and FY23 to a profit of Rs 25.23 crore in FY24. The IPO was a mainboard, book-built issue of Rs 698.06 crore, comprising a fresh issue of up to Rs 138 crore and an offer for sale of up to 1.31 crore equity shares by promoters and other shareholders, at a price band of Rs 407 to Rs 428 per share, listed on the BSE and NSE. As per the RHP, net proceeds from the fresh issue were proposed to be used for repayment of debt, funding capital expenditure requirements, investment in subsidiary Bizdent Devices Private Limited, and general corporate purposes.
Standalone · ₹ in Crores
| Particulars | FY Mar 2022 | FY Mar 2023 | FY Sep 2024 |
|---|---|---|---|
| Total Revenue | 138.07 | 163.84 | 117.9 |
| Profit After Tax (PAT) | -18.68 | -4.16 | 22.74 |
| EBITDA | - | - | - |
| Total Assets | 102.75 | 96.54 | 158.22 |
| Net Worth | 22.94 | 19.48 | 67.09 |
| Reserves & Surplus | - | - | - |
| Total Borrowing | 29.63 | 31.44 | 40.91 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | FY 2024 | Mar 2024 |
|---|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 78.78% | 78.78% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 19.97% | 19.97% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 78.78% | 78.78% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 13.03% | 13.03% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 0.94x | 0.94x |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 49.59x | 49.59x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹4.88 | ₹8.27 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 87.77x | 51.73x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹2,214 Cr | ₹3,026 Cr |
The basis of allotment for Laxmi Dental IPO was finalised on 16 Jan 2025. You can check your allotment status using your PAN number or application number on the MUFG Intime India Pvt.Ltd portal or BSE.
The Laxmi Dental IPO is expected to open in Jan 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Laxmi Dental IPO is ₹407.00 - ₹428.00 per share.
As per market sources, Laxmi Dental IPO GMP is currently ₹145.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Laxmi Dental IPO stands at 114.42x overall.
The listing date for Laxmi Dental IPO is 20 Jan 2025.
No comments yet. Be the first to comment!
